CNS Inflammatory Demyelination
- Surveillance commences in September 2009 for a period of 13 months
- Aims: To dertermine incidence of the condition; to report clinical features and distribution; and to monitor short term outcomes
- Funded: Multiple Sclerosis Society and
Action Medical Research Charities
- Ethics approval.
Black Country Research Ethics Committee (09/H1202/92) and NIGB Ethics and Confidentiality Committee approvals ( ECC/BPSU 4-03 [FT1] /2009
- Lead investigator: Dr Michael Absoud
- Project supervisors: Dr Evangeline Wassmer and Dr Carole Cummins
- Email:
michaelabsoud@childdemyelination.org.uk or
michael.absoud@bch.nhs.uk
For more information on this project visit the navigation bar.
Dr Michael Absoud
|
